Altair
Skip to content

Trading Analysis Report: AMZN

Analysis date: 2026-10-21 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-21
  • Rating: Hold
  • Generated: 2026-10-21 12:12:41
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Hold

Current Price: 264.30 (as of 2026-10-21; the bar is likely partial/intraday at 19.65M shares)

Price Target: 267

Confidence: Medium. The Hold and its sizing rules are robust because every analyst converged on them and they are built around the uncertainty. Key inputs are missing, however: - AWS segment data - implied volatility - 10-Q footnotes on the ~$35B gains and ~$40B equity jump - a confirmed earnings date - FRED macro data

Time Horizon: 1-3 months (through the ~Oct 29 Q3 print, the reaction sessions and the subsequent 10-Q review)

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: The Hold is right, and I'll defend it from the aggressive side. I expect the conservative analyst to push for a trim and the neutral analyst to push for waiting on confirmation. Both would give up more than they realize.

Start with the tape. AMZN at 264.30 sits above the 10 EMA, 50 SMA and 200 SMA in textbook order. All three SuperTrends are up, and the weekly stop is 17% below price. MACD crossed zero on October 9 and has risen three sessions in a row. RSI is 58.8, OBV is at a window high, the TD counts are early, and the daily z-score of 1.67 is still short of 2. That is not an exhausted stock. Price is 0.7% under the upper Bollinger band after a run from 250 to 264 in about a week. The 265 to 267.6 cluster is a door, not a wall.

The conservative analyst will point to fading volume: 56 million, then 35 million, then 20 million. But the 20 million is a partial bar, and the technical report says so. OBV at a window high says the move is volume-confirmed, not diverging. A stock coiling under resistance on lighter volume ahead of a catalyst is normal.

The fundamentals are the bigger point. Revenue growth has gone 8.6%, 13.3%, 13.4%, 16.6%, then 19.6%, on a $200 billion quarterly base. That's rare at this scale. Operating income rose 43% year over year, margin expanded about 230 basis points, and operating cash flow is up 40%. The bear's arithmetic is right that operating cash flow covers only about 84% of capex. But capex is a bad thing only if it doesn't earn a return. Five straight quarters of accelerating revenue is the best evidence we can get before the print. Alphabet's Cloud "giving up revenue for AI capacity" and Anthropic's reported $600 billion compute commitment both point to demand outrunning supply. The owner of scarce capacity is in a good spot, and "idle chips waiting on power" is a timing problem, not a demand problem. I concede that the print will tell us which it is.

On earnings quality, I agree that the $62.6 billion of Q2 net income is not clean. About $35 billion of it looks non-operating. So don't anchor on the 21x trailing P/E. Anchor on operating income and the 25x forward, or even the roughly 29x normalized figure. For a company growing revenue near 20% with margins expanding, that is not a bubble multiple. The 8% distance from the 52-week high and the 35% bounce off the February low of 196 tell me the market has already forgiven a lot of capex anxiety.

The trader's 1:1 reward-to-risk calculation deserves a challenge. The 284 target is the August closing high, a prior reference point, not a ceiling. This stock gapped 15.3% on its last print and 9.6% on the one before. I'll be honest about the other side. February gapped down about 10% over two sessions, and April gapped up and faded, so the sample is four. A real gap down from 264 lands around 238 to 233, through the 244 floor, which is why the trader sizes for a 10% to 12% gap rather than trusting the stop. That discipline is correct, and I wouldn't drop it. But the same fat tails that frighten the conservative analyst cut both ways. If you're sized so a 12% gap is survivable, you should want to own the upside gap, not sell ahead of it.

That's also why I'd push back on any reflex to trim a position that is already within the risk budget. Trim only what the gap budget forces you to trim, not what nerves suggest. The "no adding before the print" rule is reasonable because there is no edge in the beat odds. The 53% Polymarket number is on $1,400 of volume, so it's noise. But I'd rather say plainly that the neutral approach of waiting for the Q3 scorecard has a cost. If the scorecard passes, the stock probably gaps, and the upgrade tranches get bought after the move. That's a fair price for certainty, but it is a price. Holding full standard weight through the print is how you earn the move that confirmation will charge you for.

On sentiment, the "crowded" argument rests on 9 bullish versus 1 bearish among 10 tagged StockTwits messages from a single session, and two of the nine bullish tags are off-topic or promotional. The overall score is 5.8 out of 10 with low confidence. That isn't euphoria. The Goldman note on hedge funds being overweight the Mag 7 is second-hand but worth respecting, and I don't wave it away. Real euphoria would look like RSI above 75 and a completed TD-9, and we have neither.

On macro, the best-sampled market has a 86% chance of a Fed hold, with hike odds down 18 points on the week. Recession odds are 8%. The "another hike in 2026" odds at 80% are a real headwind for growth multiples, and AI-bubble odds rose 3 points to 9%. But FRED was down, so all of this comes from prediction markets. Stocks went from 246 to 264 under this same backdrop, so I wouldn't build a sell case on it. Beta of 1.46 is the price of admission for upside. The Bezos sale at 286 was $346 million, mostly plan-based, and the stock has since been to 246 and back.

So hold. Keep the 244 daily close as the regime-change line, size for the gap, check what the premium costs before buying protection, and stay in the trade the trend is offering. The cautious view treats uncertainty as a reason to step aside, but with the weekly and monthly trends up, revenue accelerating and a sized-for-the-gap position, the uncertainty is the opportunity. Aggressive Analyst: Before I defend anything, I owe you both some corrections. The run from 250 to 264 was one session, almost all of it October 19, not a week. The 9.6% gap was last October, not the print before July's, and I shouldn't have framed it that way. "Five straight quarters of accelerating revenue" is too strong when 13.3 to 13.4 is flat and Q4 2025 is missing. OBV at a window high is a 14 million share margin, so it's a weak witness. The Anthropic number came from an AMD headline, and I can't tie it to AMZN. Nothing in the data says Bezos's August sale was plan-based. And the neutral analyst is right that we have no AWS figure, so I'm reading the thesis off consolidated revenue. I'd add AWS growth and backlog to the scorecard.

None of that changes the position, because the tape was never what I'm defending. Neutral is right that RSI, OBV and whether 265 is a door or a wall don't change anything the trader does this week. The real question is how much AMZN to carry through the print. My answer is standard weight, trimmed only where the gap budget says you're over.

To the conservative analyst: your balance-sheet case reads worse than the numbers. Yes, the current ratio fell from 1.17 to 1.03. But the three balance sheets before March showed 1.02, 1.01 and 1.05, so March was the outlier, right after the $52.8 billion raise. Cash did fall $23.6 billion, but at $78 billion it's still above the $67 billion of last September and the $58 billion of last June. Implied liabilities are up about 52% since September, but assets are up about 50% and equity about 49%, so liabilities to assets went from 49.2% to 49.7%. The leverage ratio barely moved. Your real point is that part of the asset side may be marks, and I agree that's the open item for the 10-Q. It argues against anchoring on net income, which I've already dropped. It doesn't touch a thesis built on $27.5 billion of operating income, up 43%.

On February, you say a 10 to 12% budget sits below the worst path in the sample. That path was 233 to 196 over a month. The print reaction was about 10% over two sessions. Apply those two days to 264.30 and you get about 238.5, a loss near 10%, and the trader's close-below-244 rule fires on that second close. The drift after that is what the rule is for. You'll pay some slippage on the next open, but that's not a 16% loss.

You also say sample-of-four is too small to trust, and then use 15% as the sizing input. No down gap in the sample was 15%, and the 15% was an up move. Run 15% as a stress test. The neutral analyst's observation that it lands at about 225, right on the weekly SuperTrend stop of 225.82, is a good one. But size off 12%, which is what the data supports.

Your "cost of waiting is bounded, cost of being wrong isn't" doesn't hold up, because both are bounded by position size. That is the thing we're arguing about. If you're sized so a 15% gap is survivable, being wrong is bounded by construction.

On the marginal share, "no edge on the beat odds" is a statement about the print. It isn't a statement about whether to own the stock at standard weight. Trimming a quarter is zero expected value on the event, a bet on the print like any other. It's justified only by variance, and neutral's cap formula handles that precisely, where a quarter taken across the board doesn't.

On collars, selling a call near 284 sells exactly the tail the position exists to own. From here, July's gap would be about 305. Calling 284 a level the stock "failed to hold" ignores that it held 271 to 284 for weeks. If you want protection, price a put or a put spread and see what it costs, as the trader's plan says.

To the neutral analyst: I mostly accept your cap, the lesser of standard weight and loss budget divided by gap. That is my "trim only what the budget forces" in a formula. I'd only argue the input. At a 1.5% loss budget, 15% gives a 10% weight and 12% gives 12.5%. I'd take 12.5%. A forced sale by the 27th is fine if you're over the cap.

On "survivable isn't positive expected value," agreed. But you made the symmetric point yourself: fat tails run both ways, and this is a roughly fair bet with high variance. In a fair bet inside an uptrend, I'd rather sit at the neutral weight than below it.

Your post-print rules make my case for me. Don't chase a gap up and don't rebuild after a gap down. That means the shares you carry in are your only participation in the move. Your July example, where holders kept the gain only if they sold some, is an argument for rebalancing after the gap, which I accept. It isn't an argument for owning less before it. The July holder from 235.50 is also still up about 12% at 264.

So I'm holding, with a cap and a 244 close rule treated as a reassessment trigger, not protection. I'd stress-test at 15%, size at 12%, and not sell the upside to pay for the downside. Aggressive Analyst: Before the disagreements, here is where we've landed. All three of us carry the lesser of standard weight and the loss budget divided by the gap. We do nothing if AMZN is under that cap and trim only the excess if it's over. We make no adds before the print, and the 244 close is a reassessment trigger, not protection. That leaves the stress input, how to handle the excess, and whether my carried shares are my only participation.

Neutral, your two-limit rule is right, but your arithmetic on where the stress limit binds is off, and the fix matters. With a 1.5% base budget, base over 12% gives 12.5%. A stress limit over 15% only binds if it's below 1.875%, which is 25% above base. At exactly 25% above, the two numbers tie at 12.5%. The 10% cap only appears if your stress limit equals your base, meaning you tolerate no extra loss in the tail case. So unless someone insists on a stress loss no larger than the base, 12.5% stands. Conservative is right that a stress test needs its own limit, and I accept that. Set both limits before the print and trim if either is breached. That's the version of "size at 12, stress at 15" I should have said the first time. I'll also grant that four prints make the sample maximum a soft floor, and the unobserved tail runs both ways.

On the ladder, neutral, you said my carried shares aren't my only participation because the tranches buy after a passing scorecard. But the trader's own plan says don't chase above about 285 to 287, only 8% to 8.5% above 264.30. A July-sized gap from here lands near 305, so the ladder doesn't fire in the scenario where the print works. The ladder helps when the stock fades, and those are the scenarios where holding cost you. I'll also retract "held 271 to 284 for weeks." The data supports about two and a half weeks before it was back under 268, and a mid-September low of 246. That is a strong argument for rebalancing after a gap. It is not an argument for owning less before one.

You also said a trend gives a tilt, not a basis for sizing a binary event. I'm not sizing on the trend. Standard weight is the default, and the burden is on whoever departs from it. Variance justifies a cap, and we've built one. You've called this a roughly fair bet with high variance, and conservative has dropped the bad-reward-to-risk framing. A fair bet on a beta-1.46 stock in a weekly uptrend, with operating income up 43% and margin at 13.7%, doesn't argue for going underweight. Underweight is its own position on the print.

Conservative, you're right that I can't discard the unexplained $40 billion as earnings quality and count it as equity for leverage. Neutral's stripped-down figure is 51.5% liabilities to assets against 49.2% in September. On the harshest reading that's a 2.3-point drift in nine months. Liabilities going from about $358 billion to $544 billion against roughly $3 billion of trailing free cash flow is exactly what the print tests. It belongs on the scorecard with the debt and cash lines, but it doesn't change the cap. The same goes for the missing FRED data. You said you don't size up into a rate backdrop you can't see, but nobody is sizing up. The plan is no adds. Missing yields and VIX widen the stress case, which the stress limit already covers.

On hedging, I'm glad the 284 call is gone. Neutral is right that a call at 305 won't pay for much. The put spread, long near 252 and short near 225, is the one structure I'd accept, because it keeps all the upside. But apply it only to the excess above the cap, and remember that its premium is a sure cost while the payoff comes only in the bad outcome. With no implied volatility data, quotes decide. If taxes aren't a factor, working a limit at 265 to 267 on the excess is cheaper than insuring it. I'll accept the October 27 deadline. It costs one session and keeps us from rationalizing a missed trim.

On the book-level check, you're right that the budget belongs to the whole portfolio, and neutral is right not to apply a 15% AMZN gap to everything else. Run both checks. I don't know the caller's holdings, so this is a formula, not a number. If the AI-heavy sleeve is over, trim it by conviction, and AMZN is not automatically the name to cut.

What I won't accept is the idea that missing inputs and no edge on the beat justify a smaller position than the cap allows. The unknowns widen the band of outcomes without pointing it down. The most important unknowns, AWS growth, backlog, capex guidance and the size of the non-operating gains, all resolve in about eight days. If the print is good, the stock won't wait for a tranche ladder that tells you not to chase.

So it's still Hold. Carry up to the cap, with a 12% base and a 15% stress limit each set in advance. Trim or put-spread only the excess, make no adds, and treat the 244 close as a reassessment, not a shield. Aggressive Analyst: Let me start with where the three of us ended up, because it's a good place to be. Carry the lesser of standard weight and the loss budget over the gap. Add nothing before the print. Trim or hedge only the excess. Treat 244 as a reassessment trigger, not a shield. If your standard weight is under the cap, the whole argument resolves to doing nothing. That is the Hold, and it's the aggressive position. At a 1.5% budget the cap is 10 to 12.5% of the book. Someone at a 5 or 6% weight loses under 1% of the portfolio on a 15% gap. For that person, the tape, the Fed odds and the OBV argument shouldn't change a single share before the 29th.

Now the leftovers.

Conservative, I'll take your tie-breaker for someone who can only name one loss number, with one flag. People usually state a number with a bad-but-normal outcome in mind, not the tail. The first move should be to ask which case it was for. If they can't say, use 15% and give up the 2.5 points of weight. That's cheap enough that I won't fight it. But I'd rather have a default that gets questioned than a rule that quietly takes the tighter answer whenever information is missing.

On the stress gap, I'm with neutral. "The widest gap we can't rule out" has no stopping point. 15% is 1.5 times the largest down reaction in the sample, and it lands at about 225, on the weekly SuperTrend stop at 225.82. Past that line the weekly trend rule is doing the work. If someone wants 20%, they should say what evidence moves them from 15, and nobody here has any.

Neutral, splitting restoring standard weight from going above it fixes the one real flaw in the plan. If you trimmed to the cap and the scorecard passes, rebuilding is a weight decision, not a chase. Stage it over the first two sessions with no 285 price cap, and keep the 1.25x upgrade price-disciplined. I accept that. I'll also give you a fact against myself. October 2025 gapped to 244.22 and the close was 232.99 on the eve of February's drop. So at least point to point, all three gap-ups gave something back. That's why I'm fine with rebalancing after the gap. But the trim has a price. If you sell at 266 and it opens at 300, you rebuy at 300. That's the real cost of the cap, and it's why I'd size at 12% and not stretch the input any further.

On the sleeve check, I'll move on ordering but not on double counting. If the AI sleeve is over its shared-shock limit, rank by event variance this week, not by long-run conviction. But the shared-shock check is about weight times beta against a market-style move. AMZN's dated print is an idiosyncratic risk, and its own cap already paid for that. If AMZN is at its cap, the sleeve overage should come off in proportion to shared exposure, with conviction as the tie-breaker. It shouldn't come off AMZN a second time just because its date is on the calendar. Meta, if you own it, gets the same treatment.

On the put spread, conservative called it a hedge for the middle of the tail, not insurance. I'd say the middle of the tail is the band the cap is built on. Take a long 252 put and a short 225 put. At a 12% gap, to about 232.6, the spread pays about 19.4, so the loss on the hedged slice is about 4.65% before premium instead of 12%. At 15%, the spread is capped at 27 and the loss is about 4.8% before premium. For cap purposes, that slice counts at roughly 5% plus premium. What it leaves out is the first 4.7%, which is below what the budget is meant to survive, and the move below 225, which is regime-break territory. The premium is a sure cost with no implied volatility data behind it, so quotes decide, and the expiry has to be after the reaction session.

On execution, I agree with both of you. If you're well over the cap, put the limit in the 265 to 267 zone on now. That's where the stock stalled twice, so it's the cheapest place to sell. If it hasn't filled, sell or hedge at the Tuesday the 27th close. A one-percent price improvement isn't worth a five-session wait with Meta in the middle. Confirm the Fed date and the earnings date today, since both are inferred.

I've given up a lot in this debate: five straight quarters of acceleration, the week-long run, OBV as independent confirmation, and the Anthropic number. What survives is the P&L. Operating income is up 43%. Margin is up about 230 basis points to 13.7%. Revenue growth went from 16.6% to 19.6% on a $200 billion quarter. That is what you're holding through the print, and the cap makes sure you can hold it without needing to be right about it. So write down both loss numbers today, trim or spread only what exceeds them, and rebuild in stages afterward. If you're under the cap, you have nothing to do until the scorecard arrives, and I'd rather wait for it at full weight. Aggressive Analyst: We've converged enough that I'll go through the last items and give back what I owe.

Neutral, you're right that "it all resolves in eight days" was too strong. The print gives one more data point, not a verdict on whether $54 billion a quarter of capex earns its return. I'm also dropping the 225.82 coincidence as an answer for the tail. Conservative is right that a close-based stop tells you whether to stay after a move, not what the move costs. So 15% is where we've chosen to stop, and anything beyond it is accepted risk the caller should know about. It's also a generous stopping point on the downside. A padded 12% plus an ordinary 2.4% day gets you to about 14%, and the worst down reaction in our sample was under 10%.

You're right that the trader's pass thresholds only mean nothing got worse, but it isn't a trivial bar. $215 billion needs about a 7.2% sequential step, and last year's Q2 to Q3 step was 7.4%. So a pass means growth holds near 19%, capex intensity stays near 27%, and margin stays at 13.7%. I accept your rule. A pass returns you to standard weight in two stages, and going above standard needs AWS growth and backlog, better cash coverage, and the non-operating gains explained. I'd add two refinements. First, define "improving" for coverage in numbers today. The thresholds put coverage at about 85% against 84% now, and a point of noise shouldn't decide an upgrade. Second, tie the non-operating gains to the 10-Q footnotes, so they gate the 1.25x step but don't hold up the return to standard. Conservative's condition that the first stage wait for capex guidance costs us nothing. That stage trades after the open anyway, and the call should come before it.

Conservative, you're right that the 69% year-over-year operating income number will look green almost by arithmetic, so I'll use the sequential 7% instead. But the 230 basis points I've been citing compares Q2 with Q2, 11.4% to 13.7%, not with the weak 9.7% quarter. Q1 tells the same story, 11.8% to 13.1%, so the margin case doesn't lean on a flattering comparison. On "already in the price," the stock gapped on the Q2 numbers in July, ran to 284, then drifted back to 246 over six weeks. That looks more like doubt about capex than satisfaction with margins. At 25x forward and 8% off the high, I wouldn't call it fully priced. I'm not claiming an edge from that. I'm saying it's no reason to sit below standard weight.

On the sleeve check, I'll take your tie-break. If the shared-shock limit binds, the name with a dated event and a 1.46 beta is a sensible first cut. My one condition is that the check has to actually bind first. AMZN's own cap already paid for AMZN's own print.

On the hedge, you're right that a put spread's debit is gone for certain. But selling the excess has a cost too. If you sell at 266 and the stock opens near 305, as July's gap implies, that slice has given up about 15%. I'd still default to selling the excess because the cost is known and no volatility estimate is needed. But let's not call it free. With no implied volatility data, quotes decide, and taxes are the usual reason to prefer the spread.

The Tuesday re-check is a good addition, and today's 264.30 may be a live price on a partial bar. It cuts both ways. If AMZN runs through 267, the weight has crept up, and I'm happy to sell strength into the zone where it stalled twice. If it slides toward 256, you may be under the cap without lifting a finger.

I gave up a lot in this debate: the week-long run, "five straight quarters," OBV as independent confirmation, the Anthropic number, and the idea that the print resolves everything. What survives is simple. If you're under your loss budget at 12% and 15%, you hold standard weight and do nothing until the scorecard arrives. If you're over, you sell or spread only the excess. You add nothing before the print, treat a 244 close as a reason to reassess rather than as protection, and rebuild in stages against a pass defined in advance.

If I'm wrong, the cost is bounded by the budget. If the cautious side is wrong, the cost is the upside on shares they'd have sold while already inside it. Nobody here is arguing that someone inside the cap should cut, so the disagreement left is small. It's still Hold, at full standard weight wherever the budget allows it.